Immuron (IMRN) Operating Leases (2019 - 2026)
Immuron (IMRN) posted Operating Leases of $30606.0 for Q3 2026, down 32.4% on a QoQ basis from $45272.0 in Q4 2025.
Analysis
Immuron (IMRN) Operating Leases (2019 - 2026) Analysis & Trends
Immuron has reported Operating Leases for 6 years, with the latest figure at $30606.0 in Q3 2026.
- On a quarterly basis, Operating Leases changed N/A year-over-year to $30606.0 in Q3 2026; TTM through Aug 2026 was $30606.0, a N/A change from a year earlier, with the FY2026 full-year figure at $30606.0, changed N/A from the prior year.
- Operating Leases was $30606.0 for Q3 2026 at Immuron, down from $45272.0 in the prior quarter.
- The five-year high for Operating Leases was $150263.8 in Q2 2022, with the low at $30606.0 in Q3 2026.
- Average Operating Leases over 3 years is $75380.6, with a median of $45272.0 recorded in 2025.
- The largest YoY upside for Operating Leases was 851.97% in 2022 against a maximum downside of 851.97% in 2022.
- Over 3 years, Operating Leases stood at $150263.8 in 2022, then plunged by 69.87% to $45272.0 in 2025, then plunged by 32.4% to $30606.0 in 2026.
- The last three Operating Leases figures came in at $30606.0 (Q3 2026), $45272.0 (Q4 2025), and $150263.8 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 28, 2026 | 30,606.00 |
| Dec 31, 2025 | 45,272.00 |
| Jun 30, 2022 | 150,263.78 |
| Jun 30, 2021 | 15,784.59 |
| Jun 30, 2020 | 40,049.48 |
| Dec 31, 2019 | 80,148.00 |
| Jun 30, 2019 | 10,493.07 |